Logo image of SGHT

SIGHT SCIENCES INC (SGHT) Stock Price, Quote, News and Overview

NASDAQ:SGHT - Nasdaq - US82657M1053 - Common Stock - Currency: USD

3.55  -0.13 (-3.53%)

Premarket: 3.75 +0.2 (+5.63%)

SGHT Quote, Performance and Key Statistics

SIGHT SCIENCES INC

NASDAQ:SGHT (8/7/2025, 8:00:01 PM)

Premarket: 3.75 +0.2 (+5.63%)

3.55

-0.13 (-3.53%)

Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Equipment
Statistics
52 Week High7.05
52 Week Low2.03
Market Cap183.53M
Shares51.70M
Float40.75M
Yearly DividendN/A
Dividend YieldN/A
PEN/A
Fwd PEN/A
Earnings (Next)11-05 2025-11-05/amc
IPO07-15 2021-07-15


SGHT short term performance overview.The bars show the price performance of SGHT in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 5 10 15 20 25

SGHT long term performance overview.The bars show the price performance of SGHT in the last 1, 2 and 3 years. 1 year 2 years 3 years -10 -20 -30 -40

The current stock price of SGHT is 3.55 USD. In the past month the price increased by 3.5%. In the past year, price decreased by -40.44%.

SIGHT SCIENCES INC / SGHT Daily stock chart

SGHT Competitors/Peers

The largest stocks on the US markets in the "Health Care Equipment" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
ABT ABBOTT LABORATORIES 26.95 229.76B
ISRG INTUITIVE SURGICAL INC 58.36 168.42B
BSX BOSTON SCIENTIFIC CORP 36.38 152.32B
SYK STRYKER CORP 29.29 143.83B
MDT MEDTRONIC PLC 16.59 116.90B
BDX BECTON DICKINSON AND CO 13.15 53.79B
IDXX IDEXX LABORATORIES INC 54.13 52.28B
EW EDWARDS LIFESCIENCES CORP 30.32 45.71B
RMD RESMED INC 29.34 41.08B
GEHC GE HEALTHCARE TECHNOLOGY 15.26 32.56B
DXCM DEXCOM INC 44.94 29.96B
PHG KONINKLIJKE PHILIPS NVR- NY 15.84 25.62B

About SGHT

Company Profile

SGHT logo image Sight Sciences, Inc. is an ophthalmic medical device company, which focuses on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. The company is headquartered in Menlo Park, California and currently employs 216 full-time employees. The company went IPO on 2021-07-15. The firm is focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. The firm operates through two segments: Surgical Glaucoma and Dry Eye. The product portfolio for the Surgical Glaucoma segment features the OMNI Surgical System, which is an implant-free glaucoma surgery technology indicated to reduce intraocular pressure in adult patients with primary open-angle glaucoma, and the SION Surgical Instrument is a bladeless, a manually operated device used in ophthalmic surgical procedures to excise trabecular meshwork. The product portfolio for the Dry Eye segment consists of the TearCare System (TearCare) for ophthalmologists and optometrists. TearCare is used by adult patients with evaporative dry eye disease due to meibomian gland disease (MGD), enabling clearance of gland obstructions by physicians to address the cause of dry eye disease.

Company Info

SIGHT SCIENCES INC

4040 Campbell Ave,, Suite 100

Menlo Park CALIFORNIA US

CEO: Paul Badawi

Employees: 216

SGHT Company Website

SGHT Investor Relations

Phone: 14158890550

SIGHT SCIENCES INC / SGHT FAQ

What is the stock price of SIGHT SCIENCES INC today?

The current stock price of SGHT is 3.55 USD. The price decreased by -3.53% in the last trading session.


What is the ticker symbol for SIGHT SCIENCES INC stock?

The exchange symbol of SIGHT SCIENCES INC is SGHT and it is listed on the Nasdaq exchange.


On which exchange is SGHT stock listed?

SGHT stock is listed on the Nasdaq exchange.


What is the price forecast or stock price prediction for SIGHT SCIENCES INC stock?

13 analysts have analysed SGHT and the average price target is 4.01 USD. This implies a price increase of 13.01% is expected in the next year compared to the current price of 3.55. Check the SIGHT SCIENCES INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is SIGHT SCIENCES INC worth?

SIGHT SCIENCES INC (SGHT) has a market capitalization of 183.53M USD. This makes SGHT a Micro Cap stock.


How many employees does SIGHT SCIENCES INC have?

SIGHT SCIENCES INC (SGHT) currently has 216 employees.


What are the support and resistance levels for SIGHT SCIENCES INC (SGHT) stock?

SIGHT SCIENCES INC (SGHT) has a support level at 3.33 and a resistance level at 3.79. Check the full technical report for a detailed analysis of SGHT support and resistance levels.


Is SIGHT SCIENCES INC (SGHT) expected to grow?

The Revenue of SIGHT SCIENCES INC (SGHT) is expected to decline by -9.84% in the next year. Check the estimates tab for more information on the SGHT EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy SIGHT SCIENCES INC (SGHT) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does SIGHT SCIENCES INC (SGHT) stock pay dividends?

SGHT does not pay a dividend.


When does SIGHT SCIENCES INC (SGHT) report earnings?

SIGHT SCIENCES INC (SGHT) will report earnings on 2025-11-05, after the market close.


What is the Price/Earnings (PE) ratio of SIGHT SCIENCES INC (SGHT)?

SIGHT SCIENCES INC (SGHT) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.96).


What is the Short Interest ratio of SIGHT SCIENCES INC (SGHT) stock?

The outstanding short interest for SIGHT SCIENCES INC (SGHT) is 2.72% of its float. Check the ownership tab for more information on the SGHT short interest.


SGHT Technical Analysis

ChartMill assigns a technical rating of 4 / 10 to SGHT. When comparing the yearly performance of all stocks, SGHT is a bad performer in the overall market: 84.69% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

SGHT Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to SGHT. Both the profitability and financial health of SGHT have multiple concerns.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

SGHT Financial Highlights

Over the last trailing twelve months SGHT reported a non-GAAP Earnings per Share(EPS) of -0.96. The EPS increased by 10.28% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -38.09%
ROE -63.63%
Debt/Equity 0.51
Chartmill High Growth Momentum
EPS Q2Q%8%
Sales Q2Q%-8.47%
EPS 1Y (TTM)10.28%
Revenue 1Y (TTM)-1.47%

SGHT Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 75% to SGHT. The Buy consensus is the average rating of analysts ratings from 13 analysts.

For the next year, analysts expect an EPS growth of -14.85% and a revenue growth -9.84% for SGHT


Ownership
Inst Owners50.88%
Ins Owners19.32%
Short Float %2.72%
Short Ratio7.31
Analysts
Analysts75.38
Price Target4.01 (12.96%)
EPS Next Y-14.85%
Revenue Next Year-9.84%